Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;49(7):832-837.
doi: 10.1002/dc.24749. Epub 2021 Apr 12.

The role of rapid on site evaluation on touch imprint cytology and brushing during conventional bronchoscopy

Maria Antonietta Botticella  1 , Simona De Summa  2 , Luigi Cisternino  3 , Stefania Tommasi  2 , Maria Irene Pastena  1 , Laura Schirosi  1 , Anita Mangia  1 , Fabio Mele  1 , Antonietta Lozupone  1 , Anna Scattone  1 , Michele Siciliano  1 , Rosa Sozio  1 , Francesco Alfredo Zito  1
Affiliations

The role of rapid on site evaluation on touch imprint cytology and brushing during conventional bronchoscopy

Maria Antonietta Botticella et al. Diagn Cytopathol. 2021 Jul.

Abstract

Background: The increase in immunohistochemical and molecular predictive tests in lung cancer requires new strategies for managing small samples taken during bronchoscopic procedures. The value of Rapid On Site Evaluation (ROSE) during conventional bronchoscopic procedures on endobronchial neoplasms in optimizing small biopsies and cytologlogical tissue specimens for diagnostic testing, and ancillary studies was evaluated.

Method: ROSE on touch imprint cytology (TIC) and brushing was performed on 690 consecutive cases of patients undergoing biopsies, using fiber optic bronchoscopy. Immunohistochemical assay for PD-L1, ALK, and ROS1 and molecular testing, via next generation technique for EGFR, KRAS, and BRAF, were performed.

Results: The concordance between ROSE and final diagnoses was almost perfect for brushing (sensitivity: 0.84; specificity: 0.96), and less so for touch preparations (sensitivity: 0.77; specificity: 0.89). Immunohistochemical assay for PD-L1 was evaluated on 256 bioptic cases with only six unsuitable samples. Material available for immunohistochemistry for ALK was sufficient in 151 biopsies with no inadequate cases. ROS1 was evaluated in 132 biopsies, with only two unsuitable samples. Molecular analysis was performed on 128 biopsies, 29 TIC, and 17 brushing. Out of these, only ten were considered to be unsuitable.

Conclusions: ROSE is an effective procedure for monitoring the quality and quantity of material taken during conventional bronchoscopic procedures for evaluating the suitability of small samples that must undergo immunohistochemical and molecular assay.

Keywords: ROSE; lung cancer; molecular assay; predictive tests; rapid on-site evaluation during conventional bronchoscopy.

PubMed Disclaimer

References

REFERENCES

    1. Passiglia F, Calandri M, Guerrera F, et al. Lung cancer in Italy. J Thorac Oncol. 2019;14(12):2046-2052.
    1. Roy-Chowshuri S, Dacic S, Ghofrani M, et al. Collection and handling of thoracic small biopsy and cytology specimens for ancillary studies. Arch Pathol Lab Med. 2020;144(8):933-958.
    1. Rossi G, Pelosi G, Barbareschi M, Graziano P, Cavazza A, Papotti M. Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice. Int J Surg Pathol. 2013;21:326-336.
    1. Dietel M, Bubendorf L, Dingemans AM, et al. Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European expert group. Thorax. 2016;71:177-184.
    1. Barbareschi M, Barberis M, Buttitta F, et al. Predictive markers in lung cancer: a few hints for the practicing pathologist. Pathologica. 2018;110:29-38.

Substances

LinkOut - more resources